Nissay Asset Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-48,506
Closed -$1.75M 699
2025
Q2
$1.75M Sell
48,506
-171
-0.4% -$5.67K 0.01% 539
2025
Q1
$1.52M Buy
48,677
+196
+0.4% +$6.21K 0.01% 563
2024
Q4
$1.24M Buy
48,481
+349
+0.7% +$9.25K 0.01% 608
2024
Q3
$1.36M Buy
48,132
+2,031
+4% +$56.3K 0.01% 602
2024
Q2
$1.22M Buy
46,101
+1,738
+4% +$48.2K 0.01% 602
2024
Q1
$1.35M Buy
44,363
+604
+1% +$17.8K 0.01% 586
2023
Q4
$1.23M Buy
43,759
+2,693
+7% +$74K 0.01% 582
2023
Q3
$1.11M Buy
41,066
+1,871
+5% +$55.6K 0.01% 587
2023
Q2
$1.2M Buy
39,195
+2,235
+6% +$75.7K 0.01% 565
2023
Q1
$1.33M Sell
36,960
-1,254
-3% -$46.5K 0.01% 531
2022
Q4
$1.51M Sell
38,214
-321
-0.8% -$13.4K 0.01% 497
2022
Q3
$1.55M Buy
38,535
+1,708
+5% +$73K 0.02% 474
2022
Q2
$1.55M Buy
36,827
+89
+0.2% +$3.65K 0.02% 482
2022
Q1
$1.43M Buy
36,738
+1,023
+3% +$40.2K 0.01% 549
2021
Q4
$1.42M Buy
35,715
+16,761
+88% +$651K 0.01% 567
2021
Q3
$685K Buy
18,954
+824
+5% +$32K 0.01% 675
2021
Q2
$743K Buy
18,130
+201
+1% +$8.55K 0.01% 678
2021
Q1
$782K Buy
17,929
+5,056
+39% +$240K 0.01% 652
2020
Q4
$644K Buy
+12,873
New +$546K 0.01% 649

Other funds holding RPRX